The absence of these effects in irradiated H295R and SW-13 cells expressing only endogenous mutants of p53 clearly indicates that the wild type form of this protein is required to inhibit the aberrantly activated IGF-II/Akt signal transduction pathway in ACC. The gene discussed is IGF2; the disease is adrenal cortex carcinoma.